Insider Trading (Form 4)
NASDAQ
Burning Rock Biotech Ltd. Director Yusheng Han has acquired a significant number of ordinary shares represented by American depositary shares (ADS) over several transactions in June 2026.
Schedule 13G - Passive Investments
NASDAQ
Kynam Capital Management, LP and Yue Tang have filed an amendment reporting a 13.97% beneficial ownership stake in Burning Rock Biotech Ltd.
NASDAQ
CRCM Institutional Master Fund and associated entities have filed a Schedule 13G reporting a 3.2% beneficial ownership stake in Burning Rock Biotech Ltd.
NASDAQ
CRCM Institutional Master Fund, CRCM LP, CRCM LLC, and Chun R. Ding have jointly disclosed beneficial ownership of 5.38% of Burning Rock Biotech Ltd.'s American Depository Shares.
NASDAQ
Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang collectively reported beneficial ownership of 11.01% of Burning Rock Biotech Ltd's American Depository Shares.